http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103893122-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7024 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-63 |
| filingDate | 2014-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103893122-B |
| titleOfInvention | A kind of madecassoside liposome and preparation method and application |
| abstract | The invention belongs to pharmaceutical preparation and cosmetic field, more particularly to madecassoside liposome and preparation method and application.Madecassoside and lipid components are dissolved or heated by organic solvent by the present invention to be melted, it is concentrated or dry, add the hydration medium containing madecassoside and be hydrated, lipid aqueous dispersion is made, through homogenization, madecassoside liposome is formed.The madecassoside liposome can be made into the form of emulsion, creams, lotion, suppository or freeze-dried powder, and all adopted traditional occupation modes.The present invention is using lipid components as carrier, the percutaneous abilities, sustained release and bioavailability of madecassoside can be improved, madecassoside farthest can be retained in skin, so as to effectively play effect, can especially be smeared by local skin or mucous membrane and realize Transdermal absorption. |
| priorityDate | 2014-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 40.